ScholarIQanswers from OpenAlex

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering

PaperCitations, authors & open-access status

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering have?

ScholarIQcitation count

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering has 63 citations in the OpenAlex counts ScholarIQ stores.

When was Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering published?

ScholarIQyear

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering has 2015 year in the ScholarIQ index.

What is the open-access status of Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering?

ScholarIQoa status

Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering has green oa status in the ScholarIQ index.

What is the DOI of Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering?

ScholarIQdoi

The DOI for Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering is on the source record.

What is the PMID of Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering?

ScholarIQpmid

The PMID for Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering is on the source record.

What is the OpenAlex record for Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering?

ScholarIQopenalex

The OpenAlex for Discovery of AZ0108, an orally bioavailable phthalazinone PARP inhibitor that blocks centrosome clustering is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial